Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) Despite Sell-Off; Says Business is Sustainable
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) Despite Sell-Off; Says Business is Sustainable
February 29, 2016 7:30 AM EST
DUBLIN, IRELAND -- (Marketwired) -- 02/29/16 --
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today joins rare disease patient advocates worldwide in supporting the ninth annual international Rare Disease Day.
Organized annually on the last day of February by the European Organization for Rare Diseases (EURORDIS) and supported in the United... More
February 29, 2016 7:00 AM EST
DUBLIN, IRELAND -- (Marketwired) -- 02/29/16 --
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced its fourth-quarter and full-year 2015 financial results today and confirmed its full-year 2016 net sales and adjusted EBITDA guidance.
Financial Highlights
(in millions except for per
share amounts and % %
percentages) Q4 15 Q4 14 Change FY 15 FY 14 Change
------- ------- ------ ------- ------- ------
Net sales $ 244.5 $ 103.8 135 $ 757.0 $ 297.0 155
Net income (loss) 24.0 (31.6) NM 39.5 (263.6) NM
Adjusted non-GAAP net
income 102.4 25.9 295 305.9 72.1 324
Adjusted EBITDA 122.5 34.8 252 362.1 87.1 316
Earnings (loss) per share -
basic $ 0.15 $ (0.27) NM...
More
